Dana-Farber is at the forefront of cancer research, with numerous clinical trials and studies aimed at developing new treatments and therapies. The institute collaborates with other leading research organizations and is part of the Dana-Farber/Harvard Cancer Center, a comprehensive cancer center designated by the National Cancer Institute (NCI).
